Benjamin Edwards’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Benjamin Edwards's AZN Position: Q3 2026 in Review
Benjamin Edwards increased its AstraZeneca (AZN) stake by 1% in Q3 2026, buying an estimated $46.5K and bringing the position to 27,346 shares worth $4.46M. The position accounts for 0.04% of the portfolio, ranked #376.
Benjamin Edwards first reported a position in AZN in Q1 2020 and has held it in 27 quarters since. The position peaked at $5.66M in Q1 2026. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Benjamin Edwards held 27,346 shares of AstraZeneca worth $4.46M as of Q3 2026.
- Benjamin Edwards bought 279 AstraZeneca shares in Q3 2026, an estimated $46.5K.
- AstraZeneca made up 0.04% of Benjamin Edwards's portfolio in Q3 2026, its #376 holding.
- Benjamin Edwards first reported a position in AstraZeneca in Q1 2020 and has held it in 27 quarters since.
- Benjamin Edwards's AstraZeneca position peaked at $5.66M in Q1 2026.
- 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.